{
    "eid": "2-s2.0-85144040114",
    "title": "Potential roles of hyaluronic acid in in vivo CAR T cell reprogramming for cancer immunotherapy",
    "cover-date": "2022-11-09",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Materials Science (all)",
            "@code": "2500",
            "@abbrev": "MATE"
        }
    ],
    "keywords": [],
    "authors": [
        "Chavee Laomeephol",
        "Sudartip Areecheewakul",
        "Supannikar Tawinwung",
        "Koramit Suppipat",
        "Preedakorn Chunhacha",
        "Nuno M. Neves",
        "Jittima Amie Luckanagul"
    ],
    "citedby-count": 0,
    "ref-count": 142,
    "ref-list": [
        "Chapter 30 - Adoptive Cellular Therapy With Synthetic T Cells as an \u201cInstant Vaccine\u201d for Cancer and Immunity",
        "Chapter 18 - Genetically Engineered (T Cell Receptor) T Cells for Adoptive Therapy",
        "FDA approves fourth CAR-T cell therapy",
        "In Situ Programming of CAR T Cells",
        "Engineering and Design of Chimeric Antigen Receptors",
        "The Future: In Vivo CAR T Cell Gene Therapy",
        "Toxicity and management in CAR T-cell therapy",
        "In vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy",
        "Polymeric nanoparticles for gene delivery",
        "Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting",
        "Chapter 10 - Targeted delivery of nanoparticles",
        "In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design",
        "The where, when, how, and why of hyaluronan binding by immune cells",
        "Human T Cell Development, Localization, and Function throughout Life",
        "Chapter 1 - Versatile hyaluronic acid nanoparticles for improved drug delivery",
        "Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion",
        "New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape",
        "Cellular immunotherapies for cancer",
        "Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression",
        "Adoptive cell transfer as personalized immunotherapy for human cancer",
        "TCR-T Immunotherapy: The Challenges and Solutions",
        "Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons",
        "CAR T cell immunotherapy for human cancer",
        "The growing world of CAR T cell trials: a systematic review, Cancer Immunology",
        "Design and development of polymers for gene delivery",
        "Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide",
        "Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application",
        "Gene therapy and DNA delivery systems",
        "COVID-19 Vaccine Frontrunners and Their Nanotechnology Design",
        "PEGylation as a strategy for improving nanoparticle-based drug and gene delivery",
        "Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system",
        "Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications",
        "CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment",
        "Receptor-mediated gene delivery into human mesenchymal stem cells using hyaluronic acid-shielded polyethylenimine/pDNA nanogels",
        "A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery",
        "Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy",
        "Positive hyaluronan/PEI/DNA complexes as a target-specific intracellular delivery to malignant breast cancer",
        "Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery",
        "Hyaluronic acid conjugated \u03b2-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery",
        "Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy",
        "Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes",
        "Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid",
        "Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate",
        "DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice",
        "Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy",
        "The Possible \u201cProton Sponge\u201d Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH",
        "Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery",
        "Chondroitin Sulfate-Coated DNA-Nanoplexes Enhance Transfection Efficiency by Controlling Plasmid Release from Endosomes: A New Insight into Modulating Nonviral Gene Transfection",
        "Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels",
        "Antisense Oligodeoxynucleotide-Conjugated Hyaluronic Acid/Protamine Nanocomplexes for Intracellular Gene Inhibition",
        "In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles",
        "Optimization of the Conditions for Plasmid DNA Delivery and Transfection with Self-Assembled Hyaluronic Acid-Based Nanoparticles",
        "Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors",
        "Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes",
        "Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer",
        "Glutathione: overview of its protective roles, measurement, and biosynthesis",
        "Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities",
        "Stimuli-responsive HA-PEI nanoparticles encapsulating endostatin plasmid for stem cell gene therapy",
        "Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate",
        "Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy",
        "Chitosan/TPP-hyaluronic acid nanoparticles: a new vehicle for gene delivery to the spinal cord",
        "Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection",
        "Target Specific Intracellular Delivery of siRNA/PEI-HA Complex by Receptor Mediated Endocytosis",
        "Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: Protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation",
        "Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44",
        "The Role of CD44 in Disease Pathophysiology and Targeted Treatment",
        "Hyaluronic Acid-Based Nanomaterials for Cancer Therapy",
        "Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy",
        "Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta",
        "Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target",
        "Improving the osteogenesis of rat mesenchymal stem cells by chitosan-based-microRNA nanoparticles",
        "Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles",
        "Porous Chitosan Scaffolds with Embedded Hyaluronic Acid/Chitosan/Plasmid-DNA Nanoparticles Encoding TGF-\u03b21 Induce DNA Controlled Release, Transfected Chondrocytes, and Promoted Cell Proliferation",
        "Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System",
        "Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy",
        "Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles",
        "Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression",
        "Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy",
        "Hyaluronan as an immune regulator in human diseases",
        "Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer",
        "Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery)",
        "Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers",
        "Hyaluronan binding identifies the most proliferative activated and memory T cells",
        "CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation",
        "Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response",
        "Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration",
        "CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation",
        "Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site",
        "Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators",
        "Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells",
        "CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q",
        "The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake",
        "In vivo studies with antisense oligonucleotides",
        "The effects of coating pDNA/chitosan complexes with chondroitin sulfate on physicochemical characteristics and cell transfection",
        "Preparation of Calcium Phosphate Nanocapsule Including Deoxyribonucleic Acid-Polyethyleneimine-Hyaluronic Acid Ternary Complex for Durable Gene Delivery",
        "T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy",
        "Global Manufacturing of CAR T Cell Therapy",
        "Viral vector platforms within the gene therapy landscape",
        "AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia",
        "Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells",
        "Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors",
        "In Vivo Generation of CAR T Cells Selectively in Human CD4(+) Lymphocytes",
        "In vivo generated human CAR T cells eradicate tumor cells",
        "Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors",
        "In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome",
        "Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8",
        "In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers",
        "In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo",
        "CAR T cells in solid tumors: challenges and opportunities",
        "Gene therapy for cancer: regulatory considerations for approval",
        "CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart",
        "Targeting cardiac fibrosis with engineered T cells",
        "CAR T cells produced in vivo to treat cardiac injury",
        "Genetic in vivo engineering of human T lymphocytes in mouse models",
        "Highly efficient reverse transfection with siRNA in multiple wells of microtiter plates",
        "Work Flow for Multiplexing siRNA Assays by Solid-Phase Reverse Transfection in Multiwell Plates",
        "A Reverse Transfection Technology to Genetically Engineer Adult Stem Cells",
        "Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells",
        "Accelerated transgene expression of pDNA/polysaccharide complexes by solid-phase reverse transfection and analysis of the cell transfection mechanism",
        "Controlled gene-eluting metal stent fabricated by bio-inspired surface modification with hyaluronic acid and deposition of DNA/PEI polyplexes",
        "Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA",
        "A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies",
        "Roadmap and strategy for overcoming infusion reactions to nanomedicines",
        "Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines",
        "Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory",
        "Current status of non-viral gene therapy for CNS disorders",
        "Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis",
        "Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue",
        "Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles",
        "Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery",
        "Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer",
        "Enhanced endosomal escape of dendrigraft poly-L-lysine polymers for the efficient gene therapy of breast cancer",
        "An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor",
        "Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene",
        "A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy",
        "A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery",
        "Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery",
        "Enhanced Transfection of Human Mesenchymal Stem Cells Using a Hyaluronic Acid/Calcium Phosphate Hybrid Gene Delivery System",
        "Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice",
        "CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy",
        "Systemic biodistribution and hepatocyte-specific gene editing with CRISPR/Cas9 using hyaluronic acid-based nanoparticles"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Braga",
            "@id": "60020475",
            "affilname": "Universidade do Minho",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020475",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199584",
            "affilname": "Chulalongkorn Cancer Immunotherapy Excellence Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199584",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Second Century Fund",
        "Asahi Glass Foundation",
        "Chulalongkorn University"
    ]
}